APA (7th ed.) Citation

Michael Habenbacher, Ulrich Moser, Ahmed Abaira, Peter Kiss, Clemens Holzmeister, Jakob Pock, . . . Alexandros Andrianakis. (2024). Investigation of Blood Count-Based Inflammatory Biomarkers as Predictors of Response to Dupilumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps. MDPI AG.

Chicago Style (17th ed.) Citation

Michael Habenbacher, Ulrich Moser, Ahmed Abaira, Peter Kiss, Clemens Holzmeister, Jakob Pock, Katharina Walla, Angelika Lang, and Alexandros Andrianakis. Investigation of Blood Count-Based Inflammatory Biomarkers as Predictors of Response to Dupilumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps. MDPI AG, 2024.

MLA (9th ed.) Citation

Michael Habenbacher, et al. Investigation of Blood Count-Based Inflammatory Biomarkers as Predictors of Response to Dupilumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps. MDPI AG, 2024.